These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 28162007)

  • 1. Clinical use of adjuvants in allergen-immunotherapy.
    Klimek L; Schmidt-Weber CB; Kramer MF; Skinner MA; Heath MD
    Expert Rev Clin Immunol; 2017 Jun; 13(6):599-610. PubMed ID: 28162007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvants in Allergen-Specific Immunotherapy: Modulating and Enhancing the Immune Response.
    Zubeldia JM; Ferrer M; Dávila I; Justicia JL
    J Investig Allergol Clin Immunol; 2019; 29(2):103-111. PubMed ID: 30418155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highlights of Novel Vaccination Strategies in Allergen Immunotherapy.
    Komlósi ZI; Kovács N; Sokolowska M; van de Veen W; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):15-24. PubMed ID: 31761116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen immunotherapy in allergic rhinitis: current use and future trends.
    Klimek L; Pfaar O; Bousquet J; Senti G; Kündig T
    Expert Rev Clin Immunol; 2017 Sep; 13(9):897-906. PubMed ID: 28532268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergy vaccines--new approaches to an old concept.
    Wheeler AW; Woroniecki SR
    Expert Opin Biol Ther; 2004 Sep; 4(9):1473-81. PubMed ID: 15335314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of adjuvants for allergen-specific immunotherapy in a murine model.
    de la Torre MV; Baeza ML; Nájera L; Zubeldia JM
    Immunotherapy; 2018 Oct; 10(14):1219-1228. PubMed ID: 30244623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvants for allergen immunotherapy: experimental results and clinical perspectives.
    Francis JN; Durham SR
    Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):543-8. PubMed ID: 15640697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy.
    Heldner A; Alessandrini F; Russkamp D; Heine S; Schnautz B; Chaker A; Mwange J; Carreno Velazquez TL; Heath MD; Skinner MA; Kramer MF; Zissler UM; Schmidt-Weber CB; Blank S
    Allergy; 2022 Mar; 77(3):907-919. PubMed ID: 34287971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adjuvants].
    Brehler R
    Hautarzt; 2017 Apr; 68(4):292-296. PubMed ID: 28130604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel immunotherapy vaccine development.
    Jutel M; Akdis CA
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):557-63. PubMed ID: 25304230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience.
    Jensen-Jarolim E; Roth-Walter F; Jordakieva G; Pali-Schöll I
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1780-1789. PubMed ID: 33753052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance.
    Montamat G; Leonard C; Poli A; Klimek L; Ollert M
    Front Immunol; 2021; 12():590054. PubMed ID: 33708195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI).
    Jensen-Jarolim E; Bachmann MF; Bonini S; Jacobsen L; Jutel M; Klimek L; Mahler V; Mösges R; Moingeon P; O Hehir RE; Palomares O; Pfaar O; Renz H; Rhyner C; Roth-Walter F; Rudenko M; Savolainen J; Schmidt-Weber CB; Traidl-Hoffmann C; Kündig T
    Allergy; 2020 Apr; 75(4):746-760. PubMed ID: 31774179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of nanoparticles for allergen-specific immunotherapy - use of silica nanoparticles as vaccination platform.
    Scheiblhofer S; Machado Y; Feinle A; Thalhamer J; Hüsing N; Weiss R
    Expert Opin Drug Deliv; 2016 Dec; 13(12):1777-1788. PubMed ID: 27321476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance.
    Berings M; Karaaslan C; Altunbulakli C; Gevaert P; Akdis M; Bachert C; Akdis CA
    J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy.
    Kirtland ME; Tsitoura DC; Durham SR; Shamji MH
    Front Immunol; 2020; 11():599083. PubMed ID: 33281825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvants and vector systems for allergy vaccines.
    Moingeon P; Lombardi V; Saint-Lu N; Tourdot S; Bodo V; Mascarell L
    Immunol Allergy Clin North Am; 2011 May; 31(2):407-19, xii. PubMed ID: 21530828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of allergen immunotherapy in allergic asthma.
    Zhang W; Lin C; Sampath V; Nadeau K
    Immunotherapy; 2018 Jun; 10(7):579-593. PubMed ID: 29569506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy.
    van de Veen W; Wirz OF; Globinska A; Akdis M
    Curr Opin Immunol; 2017 Oct; 48():74-81. PubMed ID: 28888176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.